Dianthus Grants 87,000 Stock Options to New Employees

Dianthus Therapeutics, Inc. granted non-qualified stock options for an aggregate of 87,000 shares of its common stock to six newly-hired, non-executive employees. These inducement grants, approved by the Company's independent Compensation Committee, were made to encourage employment acceptance. The options have a 10-year term, an exercise price of $106.02 per share, and vest over a four-year period.